trending Market Intelligence /marketintelligence/en/news-insights/trending/cgmxfHrZUVnoj88ef4tErg2 content esgSubNav
In This List

Rhythm Pharmaceuticals prices IPO

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Rhythm Pharmaceuticals prices IPO

Rhythm Pharmaceuticals Inc. priced its IPO of 7,050,000 common shares at $17 apiece.

The company granted underwriters a 30-day option to buy up to an additional 1,057,500 common shares at the offering price.

The shares are scheduled to start trading Oct. 5 on the Nasdaq Global Market under the symbol RYTM.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Morgan Stanley, BofA Merrill Lynch and Cowen are acting as lead book-running managers of the offering, with Needham & Co. as co-manager.